What is the management for a fetus with intrauterine growth restriction (IUGR) and a cerebroplacental ratio (CPR) less than 1 with a normal umbilical artery Doppler at 36 weeks gestation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of IUGR with CPR <1 and Normal Umbilical Artery Doppler at 36 Weeks

Plan for delivery at 37 weeks of gestation, as the Society for Maternal-Fetal Medicine recommends this timing for fetal growth restriction with decreased diastolic flow or severe FGR (EFW <3rd percentile), regardless of normal umbilical artery Doppler findings. 1, 2

Delivery Timing Algorithm

If Severe FGR (EFW <3rd percentile):

  • Deliver at 37 weeks even with normal umbilical artery Doppler 1, 2
  • Do not delay beyond 37 weeks hoping for additional growth, as stillbirth risk increases significantly 2, 3

If Moderate FGR (EFW 3rd-10th percentile):

  • Deliver at 38-39 weeks with normal umbilical artery Doppler 1, 4
  • The CPR <1 indicates brain-sparing physiology from placental insufficiency but does not change delivery timing when umbilical artery Doppler remains normal 2

Surveillance Protocol Until Delivery

Weekly monitoring is required from now until delivery: 1

  • Umbilical artery Doppler weekly to detect deterioration to absent or reversed end-diastolic velocity 1, 2
  • Cardiotocography (NST) weekly after viability for FGR without absent/reversed end-diastolic velocity 1
  • If absent end-diastolic velocity develops: Increase Doppler to 2-3 times per week and deliver immediately at 33-34 weeks 1, 2
  • If reversed end-diastolic velocity develops: Hospitalize, give corticosteroids, perform CTG 1-2 times daily, and deliver at 30-32 weeks 1

Why CPR Does Not Change Management

The Society for Maternal-Fetal Medicine explicitly recommends against using middle cerebral artery Doppler (which determines CPR) for routine clinical management of FGR (GRADE 2B). 1, 2

  • Multiple systematic reviews found insufficient high-quality evidence and wide variations in CPR accuracy for predicting perinatal outcomes 2
  • CPR <1 confirms placental insufficiency and fetal adaptation to hypoxemia, but umbilical artery Doppler remains the primary determinant of delivery timing 2
  • Current guidelines prioritize umbilical artery Doppler over CPR because it has superior evidence for guiding delivery decisions 2

Mode of Delivery

Vaginal delivery with continuous electronic fetal monitoring is appropriate if umbilical artery end-diastolic flow remains present. 2, 4

  • Cesarean delivery is not routinely indicated for FGR alone unless other obstetric indications arise or fetal intolerance of labor occurs 2, 4
  • If absent or reversed end-diastolic velocity develops, cesarean delivery should be strongly considered based on the entire clinical scenario 1, 2

Critical Pitfalls to Avoid

  • Do not rely solely on CPR to guide delivery timing - current guidelines do not support this practice (GRADE 2B) 1, 2
  • Do not delay delivery beyond 37 weeks in confirmed FGR, even with reassuring testing, as stillbirth risk increases 2, 3
  • Do not miss deterioration to absent/reversed end-diastolic velocity - this requires immediate change in management with earlier delivery 1, 5
  • Do not assume normal umbilical artery Doppler means normal outcome - late preterm IUGR fetuses may not show Doppler changes before fetal demise occurs after 34 weeks 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Fetal Growth Restriction at 36 Weeks Gestation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Timing delivery of the growth-restricted fetus.

Seminars in perinatology, 2011

Guideline

Management of Intrauterine Growth Restriction at 38 Weeks with Severe Oligohydramnios

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.